Decibel Cannabis Company Inc. announced that it has expanded its global footprint by entering into a supply agreement (the "Agreement") to provide premium dried medical cannabis flower to 4C LABS, a healthcare, technology, and pharmaceutical company focused on virtual prescribing, pharmaceutical distribution and clinical development in cannabis based medicinal products for human h ealth in the United Kingdom and Channel Islands (the "UK"). Decibel to supply 4C LABS with Qwest branded, craft-quality Medical Cannabis for distribution to UK medical cannabis patients; Decibel to grant strain exclusivity of rare and unique cultivars to be distributed by 4C LABS; 3-year supply agreement; Initial shipment expected before year end; Minimum purchase commitments achieve exclusivity over certain genetics and QWEST brand in the UK.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.13 CAD | +1.96% | 0.00% | 0.00% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
0.00% | 38.84M | |
+35.04% | 5.92B | |
-15.13% | 4.51B | |
-9.75% | 3.15B | |
+2.14% | 3.1B | |
-6.82% | 2.42B | |
+47.87% | 1.97B | |
-7.89% | 1.68B | |
+0.09% | 1.65B | |
-12.97% | 1.53B |
- Stock Market
- Equities
- DB Stock
- News Decibel Cannabis Company Inc.
- Decibel Cannabis Company Inc. Expands Global Footprint with Agreement to Supply Medical Cannabis to 4C Labs for Distribution in the United Kingdom